COVID-19 vaccine inequity in African low-income countries.
COVID-19 vaccine
distribution
low-income countries
uptake
vaccine coverage
vaccine equity
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
02
11
2022
accepted:
14
02
2023
entrez:
23
3
2023
pubmed:
24
3
2023
medline:
25
3
2023
Statut:
epublish
Résumé
Equitable access and utilization of the COVID-19 vaccine is the main exit strategy from the pandemic. This paper used proceedings from the Second Extraordinary Think-Tank conference, which was held by the Health Economics and Policy Unit at the Kamuzu University of Health Sciences in collaboration with the Malawi Ministry of Health, complemented by a review of literature. We found disparities in COVID-19 vaccine coverage among low-income countries. This is also the case among high income countries. The disparities are driven mainly by insufficient supply, inequitable distribution, limited production of the vaccine in low-income countries, weak health systems, high vaccine hesitancy, and vaccine misconceptions. COVID-19 vaccine inequity continues to affect the entire world with the ongoing risks of emergence of new COVID-19 variants, increased morbidity and mortality and social and economic disruptions. In order to reduce the COVID-19 vaccination inequality in low-income countries, there is need to expand COVAX facility, waive intellectual property rights, transform knowledge and technology acquired into vaccines, and conduct mass COVID-19 vaccination campaigns.
Identifiants
pubmed: 36950103
doi: 10.3389/fpubh.2023.1087662
pmc: PMC10025287
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1087662Informations de copyright
Copyright © 2023 Kunyenje, Chirwa, Mboma, Ng'ambi, Mnjowe, Nkhoma, Ngwira, Chawani, Chilima, Mitambo, Crampin and Mfutso-Bengo.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Front Public Health. 2022 Mar 07;10:821117
pubmed: 35321196
MMWR Morb Mortal Wkly Rep. 2022 Mar 04;71(9):335-340
pubmed: 35239636
NPJ Vaccines. 2021 Apr 14;6(1):54
pubmed: 33854072
Vaccines (Basel). 2022 Dec 20;11(1):
pubmed: 36679856
PLoS Med. 2021 Sep 13;18(9):e1003772
pubmed: 34516558
Rand Health Q. 2022 Aug 31;9(4):1
pubmed: 36238007
BMJ Open. 2021 Dec 15;11(12):e055159
pubmed: 34911723
PLoS One. 2021 Dec 1;16(12):e0260575
pubmed: 34851998
N Engl J Med. 2021 Jul 22;385(4):320-329
pubmed: 34192428
Nat Med. 2021 Aug;27(8):1385-1394
pubmed: 34272499
J Law Med Ethics. 2020 Sep;48(3):622-626
pubmed: 33021168
Cell Host Microbe. 2021 Jul 14;29(7):1036-1039
pubmed: 34265241
Arch Med Res. 2021 Oct;52(7):761-763
pubmed: 33941393